Houston-based NurseDash is the Uber of staffing nursing shifts in medical facilities. Photo via nursedash.com

It's no secret that there's a shortage of nurses nationwide — and in Houston, the situation is no different. As baby boomers reach old age, the need for healthcare is only becoming more dire. Most facilities see a turnover rate of between 30 and 180 percent among nurses, leaving jobs open and shifts in need of being covered. Ideal staffing is a 5:1 patient-to-nurse ratio, but many sites are getting by with more like 8:1.

The solution for most healthcare facilities, whether they're hospitals, doctors offices or nursing homes, is to contact agencies to fill those spots. But agencies charge a high percentage for placement and lack transparency, says Andy Chen, former CFO for Nobilis Health Corporation. That's why he and Jakob Kohl created their app, NurseDash.

"Historically, some local agencies will promise you that they'll have somebody for you at 7 a.m. tomorrow, then start calling their people. They promise they'll send somebody, but they don't even know who it is," says Chen.

"The other thing is [facilities] would typically call multiple agencies so you're kind of on the hook with first-come-first-serve basis. And they were incentivized to say, 'Yes I've got somebody for you,' then find the person rather than finding the right candidate for that particular shift," adds Kohl, a principal at Everwise Healthcare and an attorney.

The two men were convinced that they could do better. They wanted to make sure that high-quality, accredited nurses could match with the medical sites where they were the perfect fit, for shifts that worked for both of them. NurseDash is the platform that makes the idea a reality.

NurseDash launched in 2017 and is the product of Belgian designers and developers in Russia. The project manager for the app is in New York, but official headquarters in Houston's Galleria area, where a staff of five works with the team spread out around the world.

Since its debut, NurseDash has attracted 40 facilities in Houston, including hospitals, surgery centers, and senior living, and about 400 nurses. Chen says he isn't sure just what to call his technology yet, but compares it to the ride hailing of Uber or Lyft and calls it "a virtual bulletin board."

The healthcare site posts shifts that it needs to fill. Nurses who fit the requirements see the availability and can choose what suits their schedules, then apply within the app. Everything takes place within the app, including payment and asking questions about the job. Nurses have already been vetted before they're able to apply, with comprehensive credentialing including license checks and drug screenings. The percentage that NurseDash takes from the transaction is about 30 percent less than an agency would take, says Kohl.

It's clear why medical facilities need such a service, but how does it benefit the nurses? It depends on where they are in their careers. Experienced nurses can pick up extra shifts on top of their full-time jobs, if they so desire. Practitioners returning to the game after having children can find times that work with their busy schedules. And fledgling nurses can use the opportunities to get a foot in the door at hospitals where they'd like to work full-time someday.

"They can work on their schedule, on their terms," says Kohl.

NurseDash has already expanded beyond Houston to northeast Ohio, which the founders say has a similar competitive dynamic to the Houston market. The next goal is to hit the rest of the top 10 largest cities in the United States. The next markets, says Kohl, will roll out at the request of major hospitals with locations both in Houston and those other cities. Ultimately, the goal is to become the go-to marketplace for nurses across the country. One shift at a time, NurseDash is making healthcare better.

Patients about to undergo brain surgery can use VR to see what their surgeon is about to do to their brain. Courtesy of Methodist

5 new technologies enhancing health care at Houston Methodist

game changers

While hospital systems might have a reputation for being slow adaptors to new technologies, Houston Methodist is single-handedly trying to change that theory. From artificial intelligence to virtual reality, the hospital system is making big moves innovating and introducing cutting edge tools and systems.

Houston Methodist's Center for Innovation, which has really developed in the past few months, is lead by Roberta Schwartz — executive vice president, chief innovation officer, and chief executive officer of Houston Methodist Hospital. She says Methodist has always lead the way within health care innovation in Houston.

"I think we're an industry that is transforming itself. We're either going to be disrupted or we're going to do the disruption ourselves," Schwartz tells InnovationMap in a previous interview. "There's nobody who knows health care better than we do, so if we're going to transform the industry, I want that transformation to come from the inside."

Here are five different new programs the hospital has introduced to enhance patient care.

An automated recruiting tool named Mia

Photo via houstonmethodistcareers.org

Hospital recruiting has always posed a problem for a few reasons, but one challenge has been the lack of HR resources available at all hours of the day or night. To help rectify this issue, Methodist has introduced Mia, a 24/7 chatbot that can answer HR questions from potential applicants.

"We find that we are communicating with night nurses at 1 am asking about benefits," Schwartz says. A lot of the people we are trying to recruit are working at night when we don't have HR staff in the office all night long."

Methodist is one of five in the country to launch the recruiting chatbot. The initial pilot is focused on recruiting medical surgical nurses and medical assistants. In just four months, Mia has chatted with over 800 prospective employees resulting in over 20 hires.

Pre- and post-op automated information

Photo via caresense.com

A crucial time for patients is immediately before and after surgeries or procedures, but doctors and medical staff usually has the most trouble keeping track of patients during these times.

CareSense automated program offers reminders and monitoring questions that better connects the patients with the hospital. In the three months the pilot has been running, nearly 500 Houston Methodist surgical patients reported extremely high satisfaction and over 75 percent of patients are engaged with the program.

Currently, CareSense works with Houston Methodist patients undergoing certain total joint replacement, colorectal, spine, and cardiac procedures. The technology can send texts, emails, website, and video links before and after the procedure. Early data has seen a reduction in missed appointments, lower surgical cancellations, and increased patient compliance. Up next is an expansion into various clinical areas, including mental health, interventional radiology, and oncology.

Virtual reality technology for brain surgeries

Patients about to undergo brain surgery can use VR to see what their surgeon is about to do to their brain. Courtesy of Methodist

Houston Methodist Hospital is channeling a Magic School Bus episode with new VR technology that allows neurosurgical patients and their family members to essentially walk through their brains ahead of their surgeries.

The patient wears a virtual reality headset and gets a 360 degree view of their brain, and the neurosurgeon can walk the patient through the surgery process. According to a release from Houston Methodist, the technology is the first of its kind that combines fighter jet flight simulation with patients' anatomy scans from MRI, CT, and/or DTI processes to make a 3D model.

Virtual urgent care

Screenshot via App Store

Houston Methodist recently went mobile, Schwartz says. About 77 percent of patients are interested in virtual access to physicians, according to the Advisory Board's 2017 Virtual Visits Consumer Choice Survey that included over 5,000 patients across the country — and 19 percent of patients have already engaged with doctors virtually.

"We live in a technology-driven age where people want easy access to services and they are open to seeing a provider via video. With virtual urgent care, a patient can get help for minor illnesses from the comfort of their own home," says Schwartz in a release.

The new MyMethodist app provides a platform for patients to contact doctors virtually, as well as medical records, test results, bill payments, prescription services and more. Some of the conditions included in virtual treatment are cold/flu symptoms, pink eye, skin infections/rash, allergies, cough/fever/headache, and upper respiratory infections.

Scheduling tool partnership with Next Level Urgent Care and Blockit

Photo via nextlevelurgentcare.com

In an emergency situation, a patient might opt for an urgent care center over a hospital visit. Houston Methodist wants to connect the dots in that case in order to best serve its patients. A partnership between Blockit, Next Level Urgent Care, and Methodist has emerged to allow for easier access to follow-up appointments with orthopedic specialty physicians, and an urgent care patient might leave the facility with his or her follow-up visit already scheduled. In the pilot program's first five months into this pilot, over 120 urgent care patients engaged with the program and made follow up appointments from the facility.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.